A Seniors Guide report outlines five Medicare choices that can lead to higher costs, coverage gaps or penalties, and the deadlines beneficiaries should know.
Costly Medicare Mistakes You Should Avoid Making
The Latest
Sean Terwilliger’s Alzheimer’s Diagnosis Made Him ‘A Completely Changed Man’
After years seeking memory testing, Sean Terwilliger was diagnosed with early-onset Alzheimer’s at 60. He describes treatment, writing and unanswered questions.
15 Best Power Recliner Battery Packs in 2027
Compare 15 power recliner battery packs by capacity, connector fit, charging setup, and useful extras to find the right cordless option for your chair.
15 Best Fall Prevention Grab Bars for Safer Bathrooms and Stairs in 2027
Compare 15 fall prevention grab bars by mounting style, grip, length, and placement to find the right support for bathrooms, showers, and steps.
Declining Benzodiazepine Use Reflects More Cautious Medical Prescribing Practices
A Rutgers-led study found U.S. benzodiazepine prescription fills fell 26.7% from 2013 to 2024, alongside a decline in average dose.
10 Best Raised Toilet Seats With Arms for 2027
I compared the top raised toilet seats with arms on fit, stability, arm support and value. See which models earned the top spots and which ones to skip.
Do You Really “Need” A Joint Replacement? Why It’s More Of A Choice Than You May Think
A Sixty and Me report explains why hip and knee replacement is rarely urgent, and when surgery becomes a reasonable option to consider.
One Cognitive Test Is A Snapshot — Two Is A Trajectory: A Physician’s Take
Physician Nathaniel Chin says repeat, broad cognitive testing can help distinguish a person’s decline from lifelong differences or a bad testing day.
14 Best Cooling Products for Older Adults in 2027
A curated comparison of the best cooling products for older adults, from cooling blankets and sleep pads to neck fans and gel wraps, ranked by comfort and ease of use.
FDA Approves Once Daily Parkinson’s Pill For Treating Symptoms
The FDA approved AbbVie’s once-daily Juvmo for Parkinson’s symptoms in early disease and as an add-on later; U.S. availability is expected in October 2026.
